Terms: = Thyroid cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4 AND Prognosis
5 results:
1. miR-551b is Associated with the Poor prognosis and Malignant Development of Papillary thyroid cancer Through Regulating erbb4.
Wang J; Liu H
Horm Metab Res; 2022 Feb; 54(2):113-118. PubMed ID: 35130572
[TBL] [Abstract] [Full Text] [Related]
2. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks.
Gulfidan G; Soylu M; Demirel D; Erdonmez HBC; Beklen H; Ozbek Sarica P; Arga KY; Turanli B
Arch Biochem Biophys; 2022 Jan; 715():109085. PubMed ID: 34800440
[TBL] [Abstract] [Full Text] [Related]
3. Human epidermal growth factor receptor 4 (her4) is a favorable prognostic marker of breast cancer: a systematic review and meta-analysis.
Wang J; Yin J; Yang Q; Ding F; Chen X; Li B; Tian X
Oncotarget; 2016 Nov; 7(47):76693-76703. PubMed ID: 27736797
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract] [Full Text] [Related]
5. Biological and clinical significance of HER2 overexpression in breast cancer.
Kurebayashi J
Breast Cancer; 2001; 8(1):45-51. PubMed ID: 11180765
[TBL] [Abstract] [Full Text] [Related]
